These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6378117)

  • 1. Identification of true drug response to antidepressants. Use of pattern analysis.
    Quitkin FM; Rabkin JG; Ross D; Stewart JW
    Arch Gen Psychiatry; 1984 Aug; 41(8):782-6. PubMed ID: 6378117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placebo-controlled continuation treatment with mirtazapine: acute pattern of response predicts relapse.
    Nierenberg AA; Quitkin FM; Kremer C; Keller MB; Thase ME
    Neuropsychopharmacology; 2004 May; 29(5):1012-8. PubMed ID: 14997172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a delay in the antidepressant effect? A meta-analysis.
    Posternak MA; Zimmerman M
    J Clin Psychiatry; 2005 Feb; 66(2):148-58. PubMed ID: 15704999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of pattern analysis to identify true drug response. A replication.
    Quitkin FM; Rabkin JD; Markowitz JM; Stewart JW; McGrath PJ; Harrison W
    Arch Gen Psychiatry; 1987 Mar; 44(3):259-64. PubMed ID: 3548638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of antidepressant drug treatment. What is an adequate trial?
    Quitkin FM; Rabkin JG; Ross D; McGrath PJ
    Arch Gen Psychiatry; 1984 Mar; 41(3):238-45. PubMed ID: 6367689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different types of placebo response in patients receiving antidepressants.
    Quitkin FM; McGrath PJ; Rabkin JG; Stewart JW; Harrison W; Ross DC; Tricamo E; Fleiss J; Markowitz J; Klein DF
    Am J Psychiatry; 1991 Feb; 148(2):197-203. PubMed ID: 1987818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selecting methodologies for the evaluation of differences in time to response between antidepressants.
    Montgomery SA; Bech P; Blier P; Möller HJ; Nierenberg AA; Pinder RM; Quitkin FM; Reimitz PE; Rosenbaum JF; Rush AJ; Stassen HH; Thase ME
    J Clin Psychiatry; 2002 Aug; 63(8):694-9. PubMed ID: 12197449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DST results in nonpsychotic depressed outpatients.
    Khan A; Johnson F; Avery DH; Cohen S; Scherzo B; Dunner DL
    Am J Psychiatry; 1988 Sep; 145(9):1153-6. PubMed ID: 3046385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of the use of pattern analysis to differentiate true drug and placebo responses.
    Rothschild R; Quitkin FM
    Psychother Psychosom; 1992; 58(3-4):170-7. PubMed ID: 1488501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mousetrap: managing the placebo effect in antidepressant trials.
    Lakoff A
    Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352
    [No Abstract]   [Full Text] [Related]  

  • 11. [Placebo-controlled antidepressant drug trials. Considering the ethical implications].
    Deisenhammer EA; Hinterhuber H
    Fortschr Neurol Psychiatr; 2003 May; 71(5):243-8. PubMed ID: 12740755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of placebo-controlled trials with bupropion.
    Zung WW
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):104-14. PubMed ID: 6406436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of clinical response during placebo treatment.
    Quitkin FM; Rabkin JG; Stewart JW; McGrath PJ; Harrison W; Ross DC; Tricamo E; Fleiss J; Markowitz J; Klein DF
    Am J Psychiatry; 1991 Feb; 148(2):193-6. PubMed ID: 1987817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placebo response and antidepressant clinical trial outcome.
    Khan A; Detke M; Khan SR; Mallinckrodt C
    J Nerv Ment Dis; 2003 Apr; 191(4):211-8. PubMed ID: 12695731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accurate meta-analytical assessment of "true antidepressant effects" needed.
    Quitkin FM; McGrath PJ; Stewart JW; Klein DF; Ross DC
    J Clin Psychiatry; 2005 Sep; 66(9):1192; author reply 1192-3. PubMed ID: 16187781
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors that influence the outcome of placebo-controlled antidepressant clinical trials.
    Niklson IA; Reimitz PE; Sennef C
    Psychopharmacol Bull; 1997; 33(1):41-51. PubMed ID: 9133750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunctional attitudes in depressed patients before and after clinical treatment and in normal control subjects.
    Peselow ED; Robins C; Block P; Barouche F; Fieve RR
    Am J Psychiatry; 1990 Apr; 147(4):439-44. PubMed ID: 2180328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nefazodone: aspects of efficacy.
    Rickels K; Robinson DS; Schweizer E; Marcus RN; Roberts DL
    J Clin Psychiatry; 1995; 56 Suppl 6():43-6. PubMed ID: 7649973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of paroxetine compared with placebo in outpatients with major depression.
    Rickels K; Amsterdam J; Clary C; Fox I; Schweizer E; Weise C
    J Clin Psychiatry; 1992 Feb; 53 Suppl():30-2. PubMed ID: 1531820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.